Search Events

Event Type

October 2022


03 October - 04 October

Sponsored By:

4th Annual European Medical Device & Diagnostic Post-Market Proactive Surveillance & Vigilance Conference


Brussels, Belgium

Speakers:
Amie Smirthwaite, BEng, Ph.D. – RQM+ Senior Vice President, Intelligence & Innovation

Stop by our booth to visit the RQM+ team and don't miss our speaking session, ‘What is “proactive” PMS and how can you ensure compliance under EU MDR & IVDR?’ and our roundtable discussion on the topic of continuous benefit-risk assessment.

Register Now

13 October

11:00 AM - 12:00 PM ET | 5:00 PM - 6:00 PM CET

Presented By:

RQM+ Live! #61 — Medical Device Software: Top Deficiencies and Requests for Additional Info from FDA and Notified Bodies


Virtual Event

Speakers:
Nancy Morrison, RAC, VP, Intelligence & Innovation
Allison Komiyama, Ph.D., RAC President, AcKRS\ntelligence & Innovation - IVD
Kevin Go, RAC Project Engineer

This RQM+ Live! show will touch on anything discussed at this year's RAPS Convergence. Nothing is off-limits! We'll cover the key highlights from each of our speaker's sessions, including: Clinical evaluation, recent developments in EU regulations (MDR and IVDR), post-market clinical follow-up (PMCF) and risk management, developing IVDR-compliant intended purpose statements that serve the business and meet notified body expectations, and how to efficiently prepare your eSTAR submission.

Register Now

17 October - 18 October

Presented By:

TOPRA Medical Devices / IVDs Symposium 2022


Vienna, Austria

Speakers:
Heike Moehlig-Zuttermeister, Ph.D., RQM+ VP Intelligence and Innovation, IVD

Join Heike's panel discussion during this conference on the 19th of October during the session " IVD2: Clinical performance studies under IVDR".

Register Now

November 2022


08 November

10:00 AM - 11:00 AM ET | 4:00 PM - 5:00 PM CET

Presented By:

Webinar: Common FDA and Notified Body Software Deficiencies and How to Avoid Them


Virtual Event

Speakers:
Nancy Morrison, RAC - VP, Intelligence & Innovation
Ashley (Ash) Clark, MS, RAC - U.S. and Medical Device Principal Specialist

Notified bodies and the FDA expect to see complete software documentation, but things like inconsistency in the risk classification, failure to follow the most current or active guidance, or inadequate clinical evidence can trip up even the most seasoned regulatory professional submitting a safe and effective device for review. In this webinar, we briefly explore common findings from notified bodies and the U.S. Food and Drug Administration (FDA) and how you can avoid them!

Register Now

Blog Subscription

Subscribe to the RQM+ blog to get live shows, technical briefs, interactive tools, webinars, and more delivered to your inbox.

Need help with IVDR compliance?

Learn More

We are passionate about your success. Tell us more about your regulatory and quality needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!